Bioline Rx reported $81.67M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Bio Path BPTH:US USD 18.54M 2.47M
Bioline Rx BLRX:US USD 81.67M 13.84M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Capricor Therapeutics CAPR:US USD 50.1M 3.83M
Idera Pharmaceuticals IDRA:US USD 103.68M 77.38M